Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.160
+0.050 (4.50%)
At close: Feb 4, 2025, 4:00 PM
1.230
+0.070 (6.03%)
After-hours: Feb 4, 2025, 6:50 PM EST
Coherus BioSciences Employees
Coherus BioSciences had 306 employees as of December 31, 2023. The number of employees decreased by 53 or -14.76% compared to the previous year.
Employees
306
Change (1Y)
-53
Growth (1Y)
-14.76%
Revenue / Employee
$994,575
Profits / Employee
-$1,471
Market Cap
133.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CHRS News
- 6 weeks ago - Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025 - GlobeNewsWire
- 7 weeks ago - Coherus BioSciences: Shedding Pegfilgrastim To Fuel Ongoing Development - Seeking Alpha
- 2 months ago - Why Is Coherus BioSciences Stock Trading Higher On Tuesday? - Benzinga
- 2 months ago - Coherus Management to Participate in the 2024 Citi Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Coherus BioSciences, Inc. (CHRS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewsWire
- 6 months ago - Evaluating Coherus BioSciences: Udenyca's Success And Loqtorzi's Prospects - Seeking Alpha